Recent Finacing
Recent Raise
Amarna Therapeutics develops SV40-derived gene therapy vectors (SVac) using a proprietary SuperVero Vero-based packaging cell line, advancing AMA005 for hemophilia B and partnering with CDMO HALIX for clinical manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
